Clascoterone and minoxidil combination therapy

Abstract

The present disclosure provides a method of treating hair loss in a subject in need thereof, comprising topically administering to the subject an effective amount of cortexolone-17α-propionate and an effective amount of minoxidil. The present disclosure further provides a topical pharmaceutical formulation comprising cortexolone -17α-propionate, minoxidil, and one or more pharmaceutically acceptable carriers.